Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disorders

Mechanisms of Ageing and Development

Volumn 122, Issue 16, 2001, Pages 2005-2011

  Vanmechelen, Eugeen ^a   Vanderstichele, Hugo ^a   Hulstaert, Frank ^a   Andreasen, Niels ^b   Minthon, Lennart ^c   Winblad, Bengt ^d   Davidsson, Pia ^e   Blennow, Kaj ^e,f  

^a INNOGENETICS   (Belgium)

^b Pitea River Valley Hospital   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Medical Research Council (MRC)   (Sweden)

Author keywords

Amyloid; ; Alzheimer's disease; Cerebrospinal fluid; Dementia; Diagnosis

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL TRIAL; CONFERENCE PAPER; CREUTZFELDT JAKOB DISEASE; DEPRESSION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; EARLY DIAGNOSIS; FRONTOTEMPORAL DEMENTIA; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN CEREBROSPINAL FLUID LEVEL;

AMYLOID BETA-PROTEIN; DEMENTIA; HUMANS; PEPTIDE FRAGMENTS; TAU PROTEINS; TIME FACTORS;

EID: 0034816293     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(01)00304-9     Document Type: Conference Paper

References (36)

1. Amyloid Abeta40 CSF concentrations correlate to frontal lobe atrophy in frontotemporal dementia
2. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: Differences between early- and late-onset Alzheimer disease and stability during the course of disease
3. Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
4. Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer's disease in clinical practice
5. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology
6. Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired individuals
7. Tau protein in cerebrospinal fluid: A biochemical marker for axonal degeneration in Alzheimer disease?
8. Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
9. High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
10. Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
11. Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF
12. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay
13. Cerebrospinal-fluid tau protein and aspartate aminotransferase in Parkinson's disease
14. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: A study in Japan
15. Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies
16. Molecular classification of the dementias
17. Diagnosing dementia with Lewy bodies
18. Tau protein in cerebrospinal fluid: A new diagnostic and prognostic marker in Alzheimer disease?
19. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease
20. Tau and apo E in CSF: Potential aid for discriminating Alzheimer's disease from other dementias
21. Tau in cerebrospinal fluids: Establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau
22. Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics
23. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
24. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
25. Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
26. Cerebrospinal protein tau is elevated in early Alzheimer's disease
27. Cerebrospinal beta-amyloid (1-42) in early Alzheimer's disease: Association with apolipoprotein E genotype and cognitive decline
28. CSF levels of tau, β-amyloid (1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging
29. Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD
30. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy
31. Detection of tau in cerebrospinal fluid
32. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay
33. Development of a specific diagnostic test for measurement of β-amyloid(1-42) [βA4(1-42)] in CSF
34. Tau protein in the diagnosis of old-age dementia
35. Decreased levels of amyloid β 1-42 in cerebrospinal fluid of Creutzfeldt-Jacob disease
36. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease